Bill Sponsor
California Assembly Bill 1990
Session 20252026
Pharmacy Law: advertising certain compounded medications used for obesity or weight management.
Active
Active
Withdrawn on Jun 30, 2026
Bill Intelligence

The bill aims to regulate the sale and advertising of compounded medications for obesity or weight management. It requires pharmacists to use high-quality ingredients and maintain records for at least 2 years. Individuals or entities must provide written verification of the quality of the drug substance. Violations may result in a fine of $1,000 per dose and license revocation. The bill also prohibits deceptive advertising and imposes state-mandated local programs. It affirms that its provisions do not apply to licensed physicians and surgeons, with the goal of ensuring the safety and integrity of compounded medications.

Show more
AI-generated from the bill text (AB1990)
This content was AI-generated from the text of the bill version AB1990.
Bill Intelligence uses AI to analyze bill texts and other data. AI-generated content can contain mistakes, so the content should be reviewed for accuracy. This AI-generated content is not a replacement for reading the bill text.
If you spot anything that needs to be corrected, contact us at support@billsponsor.com or on social media.
First Action
Feb 17, 2026
Latest Action
Jun 30, 2026
Origin Chamber
Assembly
Type
Bill
Bill Number
1990
State
California
Session
20252026
Sponsorship by Party
Democrat
Author
Assembly Votes (4)
Senate Votes (1)
Summary
Existing law, the Pharmacy Law, requires the California State Board of Pharmacy within the Department of Consumer Affairs to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. Under existing law, it is unlawful for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription unless they are licensed, as specified. Existing law also requires the compounding of drug preparations by a pharmacy for furnishing, distribution, or use to be consistent with standards established in the pharmacy compounding chapters of the current version of the United States Pharmacopeia-National Formulary, including relevant testing and quality assurance. Existing law authorizes advertisements for prescription drugs, if the advertisement conforms with certain requirements, including not containing a false, fraudulent, misleading, or deceptive statement. A violation of the Pharmacy Law is a crime. This bill would make it unlawful for any person to advertise or otherwise promote certain compounded medications used for obesity or weight management, as provided, unless the advertisement is truthful and not misleading, including not containing an unsubstantiated claim with respect to the product. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
06/30/2026
Senate
Re-referred to Com. on APPR.
06/30/2026
Senate
Withdrawn from committee.
06/29/2026
Senate
From committee: Do pass and re-refer to Com. on JUD. (Ayes 7. Noes 3.) (June 29). Re-referred to Com. on JUD.
06/24/2026
Senate
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
06/22/2026
Senate
In committee: Set, first hearing. Hearing canceled at the request of author.
06/03/2026
Senate
Referred to Coms. on B. P. & E.D. and JUD.
05/27/2026
Senate
In Senate. Read first time. To Com. on RLS. for assignment.
05/26/2026
Assembly
Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 1.)
05/18/2026
Assembly
Read second time. Ordered to third reading.
05/14/2026
Assembly
From committee: Do pass. (Ayes 13. Noes 0.) (May 14).
05/14/2026
Assembly
Joint Rule 62(a), file notice suspended. (Page 5030.)
05/13/2026
Assembly
In committee: Set, first hearing. Referred to APPR. suspense file.
04/27/2026
Assembly
Re-referred to Com. on APPR.
04/23/2026
Assembly
Read second time and amended.
04/22/2026
Assembly
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 15. Noes 0.) (April 21).
04/16/2026
Assembly
Re-referred to Com. on P. & C.P.
04/15/2026
Assembly
Read second time and amended.
04/14/2026
Assembly
From committee: Amend, and do pass as amended and re-refer to Com. on P. & C.P. (Ayes 17. Noes 1.) (April 14).
03/24/2026
Assembly
In committee: Hearing postponed by committee.
03/10/2026
Assembly
Re-referred to Com. on B. & P.
03/09/2026
Assembly
From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.
03/09/2026
Assembly
Referred to Coms. on B. & P. and P. & C.P.
02/18/2026
Assembly
From printer. May be heard in committee March 20.
02/17/2026
Assembly
Read first time. To print.
Sources
Record Created
Feb 18, 2026 8:35:15 AM
Record Updated
Jul 9, 2026 4:58:08 AM